Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home News

COVID Healthcare; Hypertension Risk; and Opioid Therapy

admin by admin
August 19, 2022
in News





Biden Administration to Stop Buying COVID Vaccines, Tests

The Biden administration will stop buying COVID-19 vaccines, treatments, and tests, initiating a move beyond the crisis phase of the pandemic.

Big shift: Access to the products will shift to regular healthcare systems, with vaccines and treatments available at doctor’s offices, hospitals, and pharmacies.

Thoughtful transition: White House COVID-19 response coordinator Ashish Jha, MD, says the transition to commercial access may be complicated. Health officials are trying to be thoughtful about regulatory issues, market dynamics, and fairness.

Commercial access: Some commercial access is set to begin this fall, but most changes will be apparent in 2023.


Rich or Poor, Educated or Not, All Face Risk for Hypertension

Hypertension risk affects poorer countries as much as affluent ones, new research suggests.

Equal risk: Researchers studied a cross-section of 1.2 million adults and found that overall rates of hypertension were similar across all levels of education and wealth.

Wrong assumptions: Traditionally, other health issues like HIV, tuberculosis, and malaria received large government funding owing to hypertension’s association with obesity and sedentary lifestyle, which are more prevalent in affluent countries.

Unequal treatment: Treatment rates with blood pressure-lowering drugs were higher in countries with higher GDPs.

“Now that we know that hypertension prevalence is not different in the poorest, the least educated, or the least economically developed countries compared with their wealthier and educated counterparts, we should develop, test, and implement effective strategies to enhance global equity in hypertension care,” said Yashashwi Pokharel, MBBS, MSCR, from Wake Forest School of Medicine.


Stable, Long-term Opioid Therapy Safer Than Tapering?

Stable, long-term opioid therapy may be safer than tapering or abruptly discontinuing treatment for patients who show no signs of misuse, new research suggests.

The researchers compared three dosing strategies: abrupt withdrawal, gradual tapering, and continuation of the current stable dosage.

Increased Overdose: Participants who had a tapered dosing strategy had an increased incidence of opioid overdose or suicide vs those with a stable dosage.

Recommendations contradicted: The CDC “recommended tapering opioid dosages if benefits no longer outweigh harms,” in their 2016 Guideline for Prescribing Opioids for Chronic Pain.

“Policies establishing dosage thresholds or mandating tapers for all patients receiving long-term opioid therapy are not supported by existing data in terms of anticipated benefits even if, as we found, the rate of adverse outcomes is small,” the study investigators write.

Kaitlin Edwards is a staff medical editor based in New York City. You can follow her on Twitter @kaitmedwards. For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube.





Source link

Tags: 2019 Novel Coronavirus2019-nCoVantihypertensivecoronavirusHCoV-229EHCoV-OC43Human coronavirus 229EHuman coronavirus HKU1Human coronavirus OC43hypertensionobeseobesityopioidsvaccineWuhan coronavirus
Previous Post

Investing in health workers can help close the vaccination gap

Next Post

Think You Avoided Omicron? Think Again. Here’s Why You May Have Been Infected

Next Post

Think You Avoided Omicron? Think Again. Here's Why You May Have Been Infected

Recommended

University With Mandated Vaccination, Masking Finds No Evidence Of In-Class COVID-19 Transmission

August 8, 2022

Rejecting Science; Healthcare Bill; Climate Change Diseases

August 9, 2022

Don't miss it

Pharmaceutical

AbbVie to lift $2B deal cap as Humira rivals appear

February 6, 2023
Medicines & Healthy Lifestyle

Trial Investigating Pembrolizumab for Hormone-Sensitive Prostate Cancer Discontinued

February 6, 2023
Medicines & Healthy Lifestyle

Low Sex Drive Can Be Treated By Hormone Injections, Study Shows

February 6, 2023
News

USTR Seeks Public Comment on Restoring Tariffs on Chinese Medical Products

February 6, 2023
Pharmaceutical

Health Bulletin 6/ February/ 2023

February 6, 2023
Pharmaceutical

FDA: Base blood donation policy on science, not stigma

February 5, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.